Epigenetic modifications and noncoding RNAs in cardiac hypertrophy and failure

Area of Science:

• Cardiovascular Biology
• Molecular Genetics
• Epigenetics

Background:

• Gene expression regulation in cardiomyocytes is crucial for cardiac function.
• Dysregulation of gene programs contributes to heart failure.
• Epigenetic modifications and non-protein-coding RNAs (ncRNAs) are key players in this process.

Purpose of the Study:

• To review recent advances in understanding epigenetic modifications and ncRNAs in cardiac hypertrophy and failure.
• To explore the complex interactions between these regulatory layers in the heart.

Main Methods:

• Review of current literature on histone modifications (acetylation, methylation) and DNA methylation.
• Analysis of the roles of microRNAs and long ncRNAs in cardiac gene regulation.
• Investigation of the interplay between ncRNAs and epigenetic mechanisms.

Main Results:

• Histone acetylation is well-studied in cardiac pathophysiology, but other histone modifications and DNA methylation roles are emerging.
• MicroRNA functions are increasingly understood, while long ncRNA roles are less defined.
• The connection between ncRNAs and epigenetic modifications in the heart is poorly understood.

Conclusions:

• Epigenetic modifications and ncRNAs significantly contribute to cardiac hypertrophy and failure pathogenesis.
• The interactive network of these regulatory mechanisms is complex and requires further investigation.
• New insights highlight the importance of these layers of gene-expression regulation in cardiac disease.